Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant TLR4 (Paridiprubart Biosimilar) antibody

The Humanized Monoclonal anti-TLR4 (Paridiprubart Biosimilar) antibody is suitable to detect TLR4 (Paridiprubart Biosimilar) in samples from Human. It has been validated for FACS.
Catalog No. ABIN7829510
$211.02
Plus shipping costs $50.00
50 μg
Shipping to: United States
Delivery in 12 to 14 Business Days

Quick Overview for Recombinant TLR4 (Paridiprubart Biosimilar) antibody (ABIN7829510)

Target

TLR4 (Paridiprubart Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

Human

Host

  • 1
Humanized

Clonality

  • 1
Monoclonal

Conjugate

  • 1
This TLR4 (Paridiprubart Biosimilar) antibody is un-conjugated

Application

Flow Cytometry (FACS)

Grade

Research Grade
  • Purpose

    Anti-TLR4(paridiprubart biosimilar) mAb

    Isotype

    IgG1, K214R, L328F, N325S, kappa
  • Application Notes

    Flow Cyt 1:100

    Comment

    Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Please see Certificate of Analysis for specific instructions of reconstitution.

    Buffer

    Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized antibodies are shipped at ambient temperature.

    Expiry Date

    12 months
  • Target

    TLR4 (Paridiprubart Biosimilar)

    Alternative Name

    Paridiprubart Biosimilar

    Target Type

    Biosimilar

    Background

    Synonyms Target:toll like receptor 4, toll-like receptor 4, hToll, CD284, TLR-4
    Synonyms Antibody:EB-05, NI-0101

    UniProt

    O00206
You are here:
Chat with us!